Nesrina Imami

Nesrina Imami

Auto-generated profile, based on publicly available information

Nesrina Imami

Imperial College London, London, United Kingdom

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2019 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
Nishel Mohan ShahNishel Mohan Shah
Nishel Mohan Shah
PLPei F. Lai
Pei F. Lai
NINesrina Imami
Nesrina Imami
MJMark R Johnson
Mark R Johnson
Pregnancy involves a complex interplay between maternal neuroendocrine and immunological systems in order to establish and sustain a growing fetus. It is thought that the uterus at pregnancy transitions from quiescent to laboring state in response to interactions between maternal and fetal systems at least partly via altered neuroendocrine signaling. Progesterone (P4) is a vital hormone in maternal reproductive tissues and immune cells during pregnancy. As such, P4 is widely used in clinical interventions to improve the chance of embryo implantation, as well as reduce the risk of miscarriage and premature labor. Here we review research to date that focus on the pathways through which P4 mediates its actions on both the maternal reproductive and immune system. We will dissect the role of P4 as a modulator of inflammation, both systemic and intrinsic to the uterus, during human pregnancy and labor.

1 September 2001 in Clinical and Experimental Immunology
Verified
Journal Article
Closed access
PDF file
JPJ. Pido‐Lopez
J. Pido‐Lopez
NIN. Imami
N. Imami
RARichard Aspinall
Richard Aspinall

1 September 2000 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
JWJamie D. K. Wilson
Jamie D. K. Wilson
NINesrina Imami
Nesrina Imami
AWAmanda Watkins
Amanda Watkins
JGJas Gill
Jas Gill
PHPhillip Hay
Phillip Hay
FGFrances M. Gotch
Frances M. Gotch
In this study, we compared human immunodeficiency virus (HIV) type 1—specific proliferative responses with HIV-1—induced intracellular cytokine produ

1 November 2008 in Cell Host & Microbe
Verified
Journal Article
Closed access
Dimitris LagosDimitris Lagos
Dimitris Lagos
RVRichard James Vart
Richard James Vart
FGFiona Gratrix
Fiona Gratrix
SWSamantha Jane Westrop
Samantha Jane Westrop
VEVictoria Emuss
Victoria Emuss
CBChris Boshoff
Chris Boshoff

15 September 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
Nishel Mohan ShahNishel Mohan Shah
Nishel Mohan Shah
AHAnna A. Herasimtschuk
Anna A. Herasimtschuk
ABAdriano Boasso
Adriano Boasso
ABAdel Benlahrech
Adel Benlahrech
DFDietmar Fuchs
Dietmar Fuchs
MJMark R Johnson
Mark R Johnson
During pregnancy, the mother allows the immunologically distinct fetoplacental unit to develop and grow. Opinions are divided as to whether this represents a state of fetal-specific tolerance or of a generalized suppression of the maternal immune system. We hypothesized that antigen-specific T cell responses are modulated by an inhibitory T cell phenotype and modified dendritic cell (DC) phenotype in a gestation-dependent manner. We analyzed changes in surface markers of peripheral blood T cells, ex vivo antigen-specific T cell responses, indoleamine 2,3-dioxygenase (IDO) activity (kynurenine/tryptophan ratio, KTR), plasma neopterin concentration, and the in vitro expression of progesterone-induced blocking factor (PIBF) in response to peripheral blood mononuclear cell culture with progesterone. We found that mid gestation is characterized by reduced antigen-specific T cell responses associated with (1) predominance of effector memory over other T cell subsets; (2) upregulation of inhibitory markers (programmed death ligand 1); (3) heightened response to progesterone (PIBF); and (4) reduced proportions of myeloid DC and concurrent IDO activity (KTR). Conversely, antigen-specific T cell responses normalized in late pregnancy and were associated with increased markers of T cell activation (CD38, neopterin). However, these changes occur with a simultaneous upregulation of immune suppressive mechanisms including apoptosis (CD95), coinhibition (TIM-3), and immune regulation (IL-10) through the course of pregnancy. Together, our data suggest that immune tolerance dominates in the second trimester and that it is gradually reversed in the third trimester in association with immune activation as the end of pregnancy approaches.

4 November 2005 in AIDS
Verified
Journal Article
Closed access
CMChristopher M Mela
Christopher M Mela
CBCatherine T Burton
Catherine T Burton
NINesrina Imami
Nesrina Imami
MNMark Nelson
Mark Nelson
ASAlan Steel
Alan Steel
MARTIN GOODIERMARTIN GOODIER
MARTIN GOODIER
HIV-1 infection is characterized by increase in inhibitory receptors and loss of activating receptors on natural killer (NK) cells, resulting in loss of cell activity. Exceptionally, for an inhibitory receptor, the proportion of NK cells bearing CD94-NKG2A decreases during HIV-1 infection. It is not understood whether HIV-1 itself or other concomitant infections drive these changes. To investigate the relationship between HIV-1 viraemia and changes in C-type lectin-like receptor expression in NK cells and to investigate the effect of highly active antiretroviral therapy (HAART) on these changes. Three cohorts of patients were studied: (1) before, during and after treatment interruption in aviraemic and viraemic patients receiving HAART (n = 15); (2) HIV-1-positive treatment-naive individuals (n = 13); and (3) HIV-1-positive individuals receiving successful HAART for a minimum of 1 year without interruption (n = 11). Flow cytometry was used to study the expression of NKG2A before and after treatment interruption and to define expanded populations of NK cells in untreated and treated HIV-1-positive individuals. Assays were performed in vitro to assess the cytotoxicity of the expanded populations. Increases in plasma HIV-1 RNA during treatment interruption in aviraemic HAART-treated individuals did not influence the proportion of NK cells carrying the complex CD94-NKG2A. Loss of NKG2A NK cells corresponded to the dramatic expansion of a distinct population of cells expressing a functional activating CD94-NKG2C receptor with skewed expression of killer cell immunoglobulin-like receptor family and natural cytotoxicity receptors. Changes in the NK cell repertoire during HIV-1 infection were not a result of HIV-1 viraemia alone but resembled those associated with concomitant infections.